Heterogeneity of tumor prognostic markers: a reproducibility study applied to liver metastases of pancreatic endocrine tumors-Reference-Cited by-同舟云学术

Heterogeneity of tumor prognostic markers: a reproducibility study applied to liver metastases of pancreatic endocrine tumors

Published:2008-11-07 Issue:2 Volume:22 Page:273-281
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Couvelard Anne,Deschamps Lydia,Ravaud Philippe,Baron Gabriel,Sauvanet Alain,Hentic Olivia,Colnot Nathalie,Paradis Valérie,Belghiti Jacques,Bedossa Pierre,Ruszniewski Philippe

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol2008177.pdf

Reference37 articles.

1. Madeira I, Terris B, Voss M, et al. Prognostic factors in patients with endocrine tumours of the duodenopancreatic area. Gut 1998;43:422–427.

2. Plockinger U, Rindi G, Arnold R, et al. Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology 2004;80:394–424.

3. Tomassetti P, Campana D, Piscitelli L, et al. Endocrine pancreatic tumors: factors correlated with survival. Ann Oncol 2005;16:1806–1810.

4. Clarke MR, Baker EE, Weyant RJ, et al. Proliferative Activity in Pancreatic Endocrine Tumors: Association with Function, Metastases, and Survival. Endocr Pathol 1997;8:181–187.

5. Gentil Perret A, Mosnier JF, Buono JP, et al. The relationship between MIB-1 proliferation index and outcome in pancreatic neuroendocrine tumors. Am J Clin Pathol 1998;109:286–293.

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AKT and mTOR expression in human pancreatic ductal adenocarcinoma. Relevance for tumor biology.;Pathology - Research and Practice;2023-11

2. Tumeurs neuroendocrines digestives bien différenciées: focus sur les tumeurs pancréatiques;Bulletin du Cancer;2023-09

3. Updates in histopathological classification and tissue biomarkers of digestive neuroendocrine neoplasms: What the clinician should know;Best Practice & Research Clinical Endocrinology & Metabolism;2023-09

4. All Together Now;Surgical Pathology Clinics;2023-03

5. Spatial and temporal heterogeneity of digestive neuroendocrine neoplasms;Therapeutic Advances in Medical Oncology;2023-01